Image Credit: STAT News
STAT+: Ionis blazed trails in genetic medicine. On the cusp of a major approval, can it also be a commercial success?
Ionis is expecting a FDA decision by Dec. 19 on approval of a drug designed to improve the body’s ability to break down fats